22 May 2013
Keywords: japan, sosei, initiates, ph, sd118, japan-based, group
Article | 04 June 2007
Japan-based Sosei Group says that its collaborative project SD118, which is under development for the treatment of neuropathic pain, has
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 June 2007
21 May 2013
© 2013 thepharmaletter.com